These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
399 related items for PubMed ID: 27693733
1. Pyridoxal oxime derivative potency to reactivate cholinesterases inhibited by organophosphorus compounds. Bušić V, Katalinić M, Šinko G, Kovarik Z, Gašo-Sokač D. Toxicol Lett; 2016 Nov 16; 262():114-122. PubMed ID: 27693733 [Abstract] [Full Text] [Related]
2. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase. Bartling A, Worek F, Szinicz L, Thiermann H. Toxicology; 2007 Apr 20; 233(1-3):166-72. PubMed ID: 16904809 [Abstract] [Full Text] [Related]
3. Cholesterol Oxime Olesoxime Assessed as a Potential Ligand of Human Cholinesterases. Kolić D, Šinko G, Jean L, Chioua M, Dias J, Marco-Contelles J, Kovarik Z. Biomolecules; 2024 May 15; 14(5):. PubMed ID: 38785995 [Abstract] [Full Text] [Related]
4. Synthesis, Biological Evaluation, and Docking Studies of Novel Bisquaternary Aldoxime Reactivators on Acetylcholinesterase and Butyrylcholinesterase Inhibited by Paraoxon. Kuca K, Jun D, Junova L, Musilek K, Hrabinova M, da Silva JAV, Ramalho TC, Valko M, Wu Q, Nepovimova E, França TCC. Molecules; 2018 May 07; 23(5):. PubMed ID: 29735900 [Abstract] [Full Text] [Related]
6. Targeting organophosphorus compounds poisoning by novel quinuclidine-3 oximes: development of butyrylcholinesterase-based bioscavengers. Zandona A, Katalinić M, Šinko G, Radman Kastelic A, Primožič I, Kovarik Z. Arch Toxicol; 2020 Sep 07; 94(9):3157-3171. PubMed ID: 32583098 [Abstract] [Full Text] [Related]
8. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro. Jun D, Musilova L, Kuca K, Kassa J, Bajgar J. Chem Biol Interact; 2008 Sep 25; 175(1-3):421-4. PubMed ID: 18617161 [Abstract] [Full Text] [Related]
10. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis. Aurbek N, Thiermann H, Eyer F, Eyer P, Worek F. Toxicology; 2009 May 17; 259(3):133-9. PubMed ID: 19428953 [Abstract] [Full Text] [Related]
13. Can hydroxylamine be a more potent nucleophile for the reactivation of tabun-inhibited AChE than prototype oxime drugs? An answer derived from quantum chemical and steered molecular dynamics studies. Lo R, Ganguly B. Mol Biosyst; 2014 Jul 29; 10(9):2368-83. PubMed ID: 24964273 [Abstract] [Full Text] [Related]
14. Potential of two new oximes in reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by organophosphate compounds: an in vitro study. Costa MD, Freitas ML, Soares FA, Carratu VS, Brandão R. Toxicol In Vitro; 2011 Dec 29; 25(8):2120-3. PubMed ID: 21983245 [Abstract] [Full Text] [Related]
18. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro. Worek F, Aurbek N, Thiermann H. J Appl Toxicol; 2007 Dec 29; 27(6):582-8. PubMed ID: 17370251 [Abstract] [Full Text] [Related]
19. Oxime K027: novel low-toxic candidate for the universal reactivator of nerve agent- and pesticide-inhibited acetylcholinesterase. Kuca K, Musilek K, Jun D, Pohanka M, Ghosh KK, Hrabinova M. J Enzyme Inhib Med Chem; 2010 Aug 29; 25(4):509-12. PubMed ID: 20192902 [Abstract] [Full Text] [Related]
20. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds. Maxwell DM, Brecht KM, Sweeney RE. Chem Biol Interact; 2013 Mar 25; 203(1):72-6. PubMed ID: 22982773 [Abstract] [Full Text] [Related] Page: [Next] [New Search]